跳至主要内容
临床试验/JPRN-UMIN000007321
JPRN-UMIN000007321已完成2 期

A clinical study of alpha-Galactosylceramide pulsed dendritic cells (Chiba-NKT) in patients with advanced or recurrent non-small cell lung cancer. A phase II study. - alpha-Galactosylceramide pulsed DCs in patients with NSCLC

Department of General Thoracic Surgery, Graduate school of Medicine, Chiba University0 个研究点目标入组 35 人开始时间: 2012年2月17日最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients matching any of the following criteria. Patients who have serious complications such as severe infection or malnutrition. Patients with pleural effusion or ascites, pericardial effusion, uncontrolled brain metastasis, simultaneous double cancer, receiving corticosteroid treatment, autoimmune disease, a past history of hepatitis, positive for HBs antigen, anti-HCV antibody, anti-HIV antibody, anti-HTLV-1 antibody, severe cardiac disease(NYHA classIII or more) or respiratory disease(Hugh-Jones classIII or more). Patients with a past history of hypersensitivity to albumin. Pregnant or breast feeding women. Patients whose medical condition cannot allow leukoapheresis. Patients who are considered ineligible to participate in the clinical trial.

研究者

发起方
Department of General Thoracic Surgery, Graduate school of Medicine, Chiba University

相似试验